PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
24-Jun-2020 Orgenesis and Leidos Collaborate on Potential Treatment for COVID-19 Orgenesis Inc
24-Jun-2020 Rexgenero acquires the key technology and program assets of aratinga.bio SAS Group Rexgenero
24-Jun-2020 Intranasal immunization with Intravacc’s experimental whooping cough vaccine confers broad protection Intravacc
24-Jun-2020 Sanofi’s investigational enzyme replacement therapy shows meaningful results in clinical manifestations of late-onset Pompe disease1 Sanofi
24-Jun-2020 EPIDAREX CAPITAL CLOSES NEW £102 MILLION UK VENTURE FUND TO BUILD SUCCESSFUL LIFE SCIENCE COMPANIES Epidarex Capital
24-Jun-2020 Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial Evelo Biosciences
24-Jun-2020 Cambridge Innovation Capital plc: Annual results for the year ended 31 March 2020 Cambridge Innovation Capital plc
23-Jun-2020 (Covid-19) Impact Analysis : Medical Indoor Oxygen Concentrators Market Size, Trends, Analysis, Demand, Outlook and Forecast to 2024 Qurate Business Intelligence
22-Jun-2020 (Covid-19) Impact Analysis : Stress Management Market Size, Trends, Analysis, Demand, Outlook and Forecast to 2024 Qurate Business Intelligence
19-Jun-2020 Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of its Initial Public Offering on Euronext Brussels Hyloris Pharmaceuticals
19-Jun-2020 Sanofi announces positive long-term efficacy and safety data for fitusiran from interim analysis of Phase 2 extension study in people with hemophilia A and B, with or without inhibitors Sanofi
19-Jun-2020 Dupixent® (dupilumab) approved in China for adults with moderate-to-severe atopic dermatitis Sanofi
19-Jun-2020 Tiziana Granted First-Ever Patent on a Transformational Technology for Oral Delivery of all Anti-CD3 Monoclonal Antibodies for Treatment of Human Diseases Tiziana Life Sciences
19-Jun-2020 AACR Annual Meeting: Sermonix to present poster on lasofoxifene, CDK 4/6 combination Sermonix Pharmaceuticals
19-Jun-2020 RedHill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK RedHill Biopharma
19-Jun-2020 PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19 PTC Therapeutics, Inc
19-Jun-2020 RINVOQ™ (upadacitinib) Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis AbbVie
19-Jun-2020 Crown Bioscience Hosts Innovative Virtual AACR 2020 Conference and Tradeshow Crown Bioscience Inc
19-Jun-2020 PureTech Founded Entity Gelesis Announces Partnership for Commercial Launch of Plenity® in China PureTech Health plc
19-Jun-2020 Max Planck researchers feed Proteome AI with PharmaFluidics technology PharmaFluidics